Axis Spine Technologies secures £2.2m in a seed follow-on round led by ACF Investors to expand in the US.
The medtech start-up has raised £2.2m from ACF Investors and Mercia to fund its American market launch and product pipeline.
Axis Spine Technologies develops advanced modular spinal implant systems designed to improve correction options and safety for surgeons performing anterior surgery. The company is based in the UK.
Axis Spine Technologies has secured £2.2m in a seed follow-on funding round led by ACF Investors, with participation from Mercia and an angel syndicate. The capital will support the commercial launch of the company's inaugural device in the United States, alongside ongoing development of oblique and lateral cage implants and an advanced access system.
Founded in 2017, the company produces modular spinal implant technology that requires less insertion force than conventional devices, mitigating the risk of structural subsidence. This transaction marks the inaugural deployment from ACF Investors' Delta Fund, which targets high-potential British businesses backed by experienced sector specialists.
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Categories
About the company
Axis Spine Technologies
Axis Spine Technologies develops the next generation of modular anterior spinal implant technology.